ArticleThe Journal of allergy and clinical immunology2012

Cross-sector sponsorship of research in eosinophilic esophagitis: a collaborative model for rational drug development in rare diseases.

Robert Fiorentino et al.PubMed ↗Publisher ↗

No numbers read from the abstract.